Facelift in Curitiba BR
As we become older the gravity, sun exposure and everyday stress leave their marks on our faces. Wrinkles appear between the nose and the mouse, the skin becomes lose and drop below the jaw line and extra fat and skin accumulates around the neck. Facelift cannot stop the aging process but it can "turn back time" by removing extra skin and fat and straitening the muscles.
The ideal candidates for the procedure are patients with skin of the face and neck that started to drop but still has its elasticity.
The operation last from 3-7 hours (it can be longer if additional procedures are done). Some surgeons prefer to work on each side at a time and some do both sides simultaneously. The placement of the cuts and the magnitude of the operation depend on face structure and the correction required. The cut usually starts on the forehead goes in front of the ear and behind the ear lobe, additional cut below the chin is made to repair the neck. The surgeon separates the skin from the fat, removes the extra fat, strengthens the muscles and returns the fat pockets where they use to be. Afterwards he stretches the skin, cuts the extra and closes with sutures. A drainage tube usually left from both sides to draine secretions and blood and the face is bandaged for the first 24 hours.
Every operation has its risks although not common those include, bleeding, infection, damage to facial nerves (usually temporal), face asymmetry and delayed healing. Patients who smoke have higher rates of delayed healing.
There may be pain or uncomfortable felling after the recovery that can be treated with painkillers. A sensation of ants crawling usually disappears after weeks or a month after the surgery. Bandages are removed after a day or two and your face may look swollen. Red or pale with bleeding spots, you must remember that those will disappear after few days or weeks.
You can get out of bed after 24 hours but you should avoid any efforts for at least a week to help the healing process. You should avoid alcohol, hot tubs and saunas for at least a month. Most of the patients feel disappointed at first, their face look and feel strange but after a few weeks the scars will heal and you'll be able to see the final results. Many patients return to work after 3 weeks. Sometimes you may need to use make up to blur the hemorrhage spots.
More Curitiba info...
Curitiba Understand
Curitiba is the largest city in the prosperous Southern region, and its population is largely descended from German, Ukranian, Russian, Italian and Polish immigrants. The city is known to urban planners worldwide for its innovative public transit system.
There is a great cidade velha (old city) in the center which is restored very well for its 314 years. There is a huge arts and crafts fair every Sunday in the old city that is well worth visiting.
-
Curitiba Get around
Curitiba has a very simple and practical transportation system. Public transportation consists entirely of buses. There are several different types of bus, each with a different function.
Driving can be difficult for those who are not used to the traffic in Curitiba, specially for first comers. In the central area, there are many one-way streets, parking restrictions as well as pedestrian-only and bus-only streets. Bus lanes are very common in Curitiba, as the city has over 60 km (38 miles) of them. Most avenues are wide and have spacious sidewalks and they are mostly laid out in a grid system in the city center area.
-
Plastic Surgery News...
- According to a report by BioSpace, Abraxis Inc. has announced that it has received European marketing approval for an albumin-bound nanoparticle formulation of paclitaxel (Abraxane) for the treatment of metastatic breast cancer in patients who have failed first-line treatment for metastatic disease and for whom standard, anthracycline-containing therapy is not indicated.
According to the report, the approval is based on the results of a phase III study which showed that the albumin-bound formulation of paclitaxel was linked to a higher response rate and prolonged progression-free and overall survival compared to patients who received conventional paclitaxel (Taxol). The following results were reported in the abstract:
• 26.5% (95% confidence interval 18.98 to 34.05) of patients in the Abraxane group achieved a response compared to 13.2% (7.54 to 18.93) of patients in the Taxol group (p=0.006)
• The median time to disease progression was 20.9 weeks (15.7 to 25.9) for patients on Abraxane compared to 16.1 weeks (15.0 to 19.3) for patients on Taxol (p=0.011)
• The median progression free survival time was 20.6 weeks (15.6 to 25.9) for patients on Abraxane and 16.1 weeks (15.0 to 18.3) for patients on Taxol (p=0.010)
• Overall survival was 56.4 weeks (45.1 to 76.9) for patients on Abraxane and 46.7 weeks (39.0 to 55.3) for patients on Taxol (p=0.020)
• The most serious adverse events associated with Abraxane in study included neutropenia, anaemia, infections, sensory neuropathy, nausea, vomiting and myalgia and arthralgia. Other common adverse reactions included asthenia, diarrhoea, ocular/visual disturbances, fluid retention, alopecia, hepatic dysfunction, mucositis and renal dysfunction.
The manufacturer expects to launch the product in mid-2008.
- Researchers at the Paul Scherrer Institute (PSI) and the EPFL in Switzerland have developed a novel method for producing dark-field x-ray images at wavelengths used in typical medical and industrial imaging equipment.